PLUS THERAPEUTICS, Inc. - Common Stock (NQ:PSTV)

3.870 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about PLUS THERAPEUTICS, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

This Company's Innovative Targeted Radiation Therapy Could Offer Potential Hope for Cancer Patients ↗

November 11, 2021

Photo by National Cancer Institute on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a...

Via Benzinga

3 Penny Stocks Insiders Are Buying ↗

October 29, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...

Via Benzinga

The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO ↗

October 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Committee Recommends Approval Of Merck, Pfizer's Pneumococcal Vaccine...

Via Benzinga

The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs ↗

October 18, 2021

Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market rally and some sector-specific news....

Via Benzinga

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

Earnings Scheduled For October 21, 2021 ↗

October 21, 2021

Companies Reporting Before The Bell • Tri Pointe Homes (NYSE:TPH) is estimated to report quarterly earnings at $0.89 per share on revenue of $946.97 million. •...

Via Benzinga

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs ↗

October 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold ↗

September 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 03, 2021

Gainers Cellect Biotechnology (NASDAQ:APOP) shares rose 68.9% to $9.29 during Friday's pre-market session. The company's market cap stands at $36.4 million....

Via Benzinga

65 Biggest Movers From Yesterday ↗

September 03, 2021

Gainers AgileThought, Inc. (NASDAQ: AGIL) shares surged 69.4% to settle at $23.53 on Thursday. AgileThought 13D Filings from Chairman, CEO Manuel Senderos Fernández and...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 02, 2021

Gainers Cellect Biotechnology (NASDAQ:APOP

Via Benzinga

46 Stocks Moving In Thursday's Mid-Day Session ↗

September 02, 2021

Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 36% to $9.02 as traders circulate a tweet from popular Twitter trader Will Meade saying 'Long $ANY this is the next $SPRT...

Via Benzinga

Why Is Plus Therapeutics Stock Moving Higher On Thursday? ↗

September 02, 2021

Plus Therapeutics Inc (NASDAQ: PSTV) has entered into an agreement with RadioMedix Inc to produce the company's radiopharmaceuticals commercially....

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 02, 2021

Gainers Plus Therapeutics (NASDAQ:PSTV) shares increased by 22.1% to $2.32 during Thursday's pre-market session. The company's market cap stands at $28.0 million....

Via Benzinga

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab ↗

September 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 23, 2021

Gainers Vivos Therapeutics (NASDAQ:VVOS) stock increased by 64.84% to $6.33 during Monday's pre-market session. The market value of their outstanding shares is at $144...

Via Benzinga

25 Stocks Moving in Monday's Pre-Market Session ↗

August 23, 2021

Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) rose 48.7% to $1.13 in pre-market trading. Greenpro Capital shares gained 16% on Friday after the company announced its Angkasa-X...

Via Benzinga

Why Is Plus Therapeutics Stock Rising After Data Presentation From Brain Tumor Trial? ↗

August 23, 2021

Plus Therapeutics Inc's (NASDAQ: PSTV) shares are moving after presenting data from a Phase 1 ReSPECT trial evaluating Rhenium-186 NanoLiposome (186RNL) in recurrent...

Via Benzinga

Plus Therapeutics Shares Preclinical Data For Targeted Cancer Radiation Therapy: Highlights ↗

August 19, 2021

Plus Therapeutics Inc (NASDAQ: PSTV) has presented preclinical data of its lead investigational drug, Rhenium-186 Nanoliposome (186RNL), for leptomeningeal...

Via Benzinga

The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow ↗

August 15, 2021

Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small-...

Via Benzinga

Topics Initial Public Offering

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck ↗

August 19, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 11, 2021

Gainers Dyadic International (NASDAQ:DYAI) stock increased by 28.96% to $4.63 during Wednesday's regular session. Trading volume for this security as of 12:30 EST is...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

August 03, 2021

On Tuesday morning, 69 companies achieved new lows for the year. Intriguing Points: Las Vegas Sands (NYSE:LVS) was the largest firm by market cap to set a new 52-...

Via Benzinga

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗

August 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 27, 2021

Gainers Acutus Medical (NASDAQ:AFIB) sto...

Via Benzinga

Plus Therapeutics Shares Jump As First Patient Treated In Latest Cohort Of Brain Tumor Trial ↗

July 22, 2021

Plus Therapeutics Inc (NASDAQ: PSTV) has announced that the first patient in the eighth cohort of Phase 1 dose-escalation ReSPECT-GBM trial for recurrent...

Via Benzinga

The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO ↗

July 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical...

Via Benzinga

21 Stocks Moving in Thursday's Pre-Market Session ↗

July 22, 2021

Gainers PainReform Ltd (NASDAQ: PRFX) shares rose 123% to $7.00 in pre-market trading. Second Sight Medical Products Inc (NASDAQ: EYES) shares rose 29% to $5.57 in pre-market...

Via Benzinga

Earnings Scheduled For July 22, 2021 ↗

July 22, 2021

Companies Reporting Before The Bell • Champions Oncology, Inc. - Common Stock (NASDAQ:CSBR) is estimated to report earnings for its fourth quarter. • MarineMax,...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.